NCT05990270

Brief Summary

Aim: The aim of this study is to reveal the effect of education given to women about cervical cancer on knowledge, attitude and belief. Material and Method: This randomized controlled study was conducted with 130 who had a public hospital located in Southeast Turkey (51 experimental, 51 control).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
102

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Aug 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 28, 2023

Completed
17 days until next milestone

First Posted

Study publicly available on registry

August 14, 2023

Completed
1 day until next milestone

Study Start

First participant enrolled

August 15, 2023

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2023

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2023

Completed
Last Updated

June 24, 2024

Status Verified

July 1, 2023

Enrollment Period

2 months

First QC Date

July 28, 2023

Last Update Submit

June 20, 2024

Conditions

Cancer of CervixHPV Infection

Keywords

Cervical cancer,early diagnosis,Pap smear,

Outcome Measures

Primary Outcomes (2)

  • First Measurement: Human Papilloma Virus (HPV) Knowledge Scale

    ASSESSMENT OF WOMEN'S AWARENESS ON HPV

    Measurement at the second encounter (1 WEEK AFTER TRAINING) for each group.

  • Second Measurement:Cervical Cancer and Pap-Smear Test Health Belief Model Scale

    ASSESSMENT OF HEALTH BELIEFS

    Measurement at the second encounter (1 WEEK AFTER TRAINING) for each group.

Study Arms (2)

EXPERIMENTAL GROUP

EXPERIMENTAL

Cervical cancer education will be provided. (The training will be in three sessions, each session will last 20-30 minutes. In the training; ppt presentation for cervical cancer, HPV virus, question and answer method will be used. In addition, female pelvic anatomy, gynecological examination, how the Pap Test is done, and cervical exam on the gynecological examination model. will be explained by showing cancer pathologies ) After the training, the final test data will be obtained by applying the questionnaire again.

Behavioral: education

control group

NO INTERVENTION

Interventions

educationBEHAVIORAL

Cervical cancer education will be provided. (The training will be in three sessions, each session will last 20-30 minutes. In the training; ppt presentation for cervical cancer, HPV virus, question and answer method will be used. In addition, female pelvic anatomy, gynecological examination, how the Pap Test is done, and cervical exam on the gynecological examination model. will be explained by showing cancer pathologies ) After the training, the final test data will be obtained by applying the questionnaire again.

EXPERIMENTAL GROUP

Eligibility Criteria

Sexfemale
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • least literate, no communication problem women who agreed to participate in the study

You may not qualify if:

  • literate are women who do not have communication problems (hearing impairment, visual impairment)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kahramanmaraş ISU

Kahramanmaraş, K.Maraş, 46100, Turkey (Türkiye)

Location

Related Publications (1)

  • Gul Oztas H, Isik K. The Effect of Cervical Cancer Education Given to Women in Turkey on Knowledge, Attitudes, and Health Beliefs: A Randomized Controlled Study. Public Health Nurs. 2025 Jan-Feb;42(1):363-373. doi: 10.1111/phn.13456. Epub 2024 Oct 17.

    PMID: 39420668DERIVED

MeSH Terms

Conditions

Uterine Cervical NeoplasmsPapillomavirus InfectionsDisease

Interventions

Educational Status

Condition Hierarchy (Ancestors)

Uterine NeoplasmsGenital Neoplasms, FemaleUrogenital NeoplasmsNeoplasms by SiteNeoplasmsUterine Cervical DiseasesUterine DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital DiseasesSexually Transmitted Diseases, ViralSexually Transmitted DiseasesCommunicable DiseasesInfectionsDNA Virus InfectionsVirus DiseasesTumor Virus InfectionsDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Socioeconomic FactorsPopulation Characteristics

Study Officials

  • HATİCE GÜL ÖZTAŞ

    KahramanmaraşISU

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
None (Open Label)
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: Parallel Assignment
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD, Assist. Prof. Dr

Study Record Dates

First Submitted

July 28, 2023

First Posted

August 14, 2023

Study Start

August 15, 2023

Primary Completion

September 30, 2023

Study Completion

December 30, 2023

Last Updated

June 24, 2024

Record last verified: 2023-07

Data Sharing

IPD Sharing
Will not share

Locations

TU(1)